Search Contract Opportunities

Tuberculosis Trials Consortium Services   7

ID: 75D30120R67869 • Type: Solicitation
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Do the documents mention an incumbent contractor?
I'd like to anonymously submit a question to the procurement officer(s)

Description

Posted: June 10, 2020, 9:32 a.m. EDT

Amendment 00004 is hereby issued to post revisions to Section J of the solicitation document. Please review Amendment 00004 in it's entirety.

Amendment 00003 is hereby issued to post revisions to section L of the solicitation document. Please review amendment 00003 in it's entirety.

Amendment 00002 is hereby issued to post revisions to the PWS and Section M of the solicitation document. Please review amendment 00002 in it's entirety.

Amendment 00001 is hereby issued to post Questions and Answers and provide additional revisions to solicitation and new attachment J.12 . Please review all attachments in their entirety.

The purpose of this procurement is to support clinical trials and clinical research on the treatment, diagnosis and prevention of tuberculosis (TB) throughout the ten-year performance period 2020 -2030. Emphasis will be given to studies of latent TB infection in the United States, and studies of active TB disease both domestically and internationally. See attached Solicitation for Details.

Posted: June 5, 2020, 2:43 p.m. EDT
Posted: May 20, 2020, 4:33 p.m. EDT
Posted: May 6, 2020, 2:16 p.m. EDT
Posted: May 6, 2020, 1:44 p.m. EDT
Posted: April 16, 2020, 2:05 p.m. EDT
Show All

Overview

Agency
Centers for Disease Control and Prevention (CDC) [HHS]
Response Deadline
June 16, 2020, 3:00 p.m. EDT (original: May 18, 2020, 3:00 p.m. EDT) Past Due
Posted
April 16, 2020, 2:05 p.m. EDT (updated: June 10, 2020, 9:32 a.m. EDT)
Set Aside
None
NAICS
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
PSC
AN12 - Health R&D Services; Health Care Services; Applied Research
Place of Performance
United States
Source
SAM
Current SBA Size Standard
1000 Employees
Est. Level of Competition
High
On 4/16/20 Centers for Disease Control and Prevention issued Solicitation 75D30120R67869 for Tuberculosis Trials Consortium Services due 6/16/20. The opportunity was issued full & open with NAICS 541714 and PSC AN12.
Primary Contact
Name
Candice Simmons   Profile
Email
iie3@cdc.gov
Phone
(770) 488-1432

Documents

Posted documents for Solicitation 75D30120R67869

Question & Answer

The AI Q&A Assistant has moved to the bottom right of the page

Opportunity Lifecycle

Procurement notices related to Solicitation 75D30120R67869

Award Notifications

Agency published notification of awards for Solicitation 75D30120R67869

Contract Awards

Prime contracts awarded through Solicitation 75D30120R67869

Protests

GAO protests filed for Solicitation 75D30120R67869

Incumbent or Similar Awards

Potential Bidders and Partners

Awardees that have won contracts similar to Solicitation 75D30120R67869

Similar Active Opportunities

Open contract opportunities similar to Solicitation 75D30120R67869

Additional Details

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > CENTERS FOR DISEASE CONTROL AND PREVENTION > CDC OFFICE OF ACQUISITION SERVICES
FPDS Organization Code
7523-00254
Source Organization Code
100188028
Last Updated
July 1, 2020
Last Updated By
PI33_DR_IAE_51681
Archive Date
July 1, 2020